LabConnect, LLC Named To Inc. 5000 List Of Fastest Growing Private U.S. Companies For 10th Year

Published: Sep 26, 2017

SEATTLE--(BUSINESS WIRE)--LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, has been named to the Inc. 5000 list of the fastest growing companies in America for its 10th year. This year, LabConnect’s 115.6 percent growth rate earned it a spot on the list. Only 100 companies — 2 percent — have been on the list 10 times or more.

“According to the U.S. Census Bureau, there are about 6 million private companies in the U.S., and every year we’re delighted to be among the 5,000 to make Inc.’s fastest growing list,” said Eric Hayashi, president and CEO of LabConnect. “It is an honor to be among this remarkable group, and we are especially pleased to join the group of just 100 companies named to the list for the 10 times or more.”

Founded in 2002, LabConnect comprises a network of global central laboratories with services including routine and esoteric laboratory testing, clinical kit building, sample management, biorepository and scientific operations support services for biopharmaceutical, medical device and contract research organizations around the world.

The Inc. 5000 ranks companies by overall revenue growth over a three-year period and requires they be U.S.-based, privately held and independent — not subsidiaries or divisions of other companies. This prestigious list is known as a showcase of entrepreneurial leaders.

“I’m proud of being part of the Inc. 5000, but I’m especially proud of the LabConnect team and our ability to grow organically year after year while still maintaining the highest quality,” Hayashi said. “Growth is one thing, but it’s quality that leads to longevity.”

For more information, visit

About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at or connect with LabConnect on LinkedIn.

LabConnect, LLC
Eric Hayashi, 206-322-4680

Back to news